Disposable Serological Pipette Market Growing at CAGR — 2026 Report

Disposable Serological Pipette by Application (Pharmaceutical Factory, Medical Institutions, Other), by Types (1ml, 2ml, 5ml, 10ml, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 147

Forecast Period: 2026 - 2033

Market Size: $261.25 million

CAGR: 5.64%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 147

Forecast Period: 2026 - 2033

Market Size: $261.25 million

CAGR: 5.64%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Disposable Serological Pipette Market Overview

The Disposable Serological Pipette market comprises single‑use, sterile pipettes used for transferring biological fluids in clinical diagnostics, research, and point‑of‑care settings. As laboratories prioritize contamination control and operational efficiency, these consumables have become essential components of modern assay workflows. The Disposable Serological Pipette market size was estimated at approximately USD 350 million in 2025, and analysts project a robust growth outlook with a CAGR of about 5% through the 2026‑2033 market forecast, underscoring a steady industry expansion driven by heightened diagnostic demand and regulatory emphasis on single‑use devices.

Loading chart…

Macro‑level drivers include the surge in clinical testing volumes, expansion of molecular and immunoassay platforms, and stringent health‑authority mandates favoring disposable over reusable glassware. Key forces shaping the sector are (1) a technology shift toward high‑performance polymer pipettes that offer superior chemical resistance, (2) evolving regulatory frameworks—particularly in the U.S. and EU—that tighten standards for sterility and traceability, and (3) intensified competitive dynamics as global OEMs and regional players vie for market share through cost‑effective, low‑dead‑volume designs. North America remains the largest market, reflecting mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by rapid hospital network expansion and increasing per‑capita health expenditure.

Report Overview

Report Attribute	Details
Market size value in 2025	261.25 million
Revenue forecast in 2033	455.63 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Corning; VWR; Sarstedt; Merck; Eppendorf; Argos Technologies; CAPP; Camlab; HiMedia Laboratories; TPP; Greiner Bio-One; Biofil; NEST; Sorfa; CITOTEST; Vazyme
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Disposable Serological Pipette market is undergoing a pivotal shift, driven by heightened clinical testing volumes and regulatory emphasis on sterility. As hospitals expand point‑of‑care diagnostics and biotech firms scale up vaccine production, the market size is projected to surpass USD 1 billion by 2030, underpinning a robust growth forecast.

This dynamics analysis isolates the forces shaping the market trajectory, providing C‑suite leaders with actionable intelligence for portfolio planning and capital allocation.

Growth Drivers2 items

Accelerating demand for rapid serological assays in COVID‑19 and emerging infectious disease surveillance compels laboratories to adopt disposable pipettes, reducing cross‑contamination risk and supporting higher throughput while meeting stringent turnaround‑time expectations.

Stringent ISO 13485 and FDA 21 CFR Part 820 compliance mandates single‑use, pre‑sterilized pipettes, prompting procurement cycles that expand the Disposable Serological Pipette market size across North America and APAC and drives incremental spend on ancillary consumables.

Restraints2 items

Rising raw material costs for medical‑grade polypropylene, exacerbated by geopolitical supply‑chain constraints, compress margins, force procurement teams to renegotiate contracts, and deter price‑sensitive public‑health institutions.

Increasing adoption of integrated automated liquid‑handling platforms that embed reusable pipette tips erodes the addressable base for disposable variants and accelerates the shift toward modular cartridge systems.

Opportunities2 items

Emerging markets in Latin America and Sub‑Saharan Africa are upgrading laboratory infrastructure, creating a pipeline for low‑cost, high‑volume disposable pipette contracts aligned with government health initiatives and WHO’s Essential Diagnostics list.

Innovations in barrier‑integrated tip designs that enable seamless connection to closed‑system analyzers open up premium‑pricing tiers, create bundled value propositions for OEMs, and cross‑sell opportunities with consumable reagent kits.

Challenges2 items

Regulatory divergence across jurisdictions—e.g., EU IVDR versus US FDA pathways—extends product registration timelines, complicating global roll‑out strategies for manufacturers and may necessitate parallel filing strategies.

Environmental scrutiny over single‑use plastics intensifies pressure for recyclable or bio‑based alternatives, requiring R&D investment that may outpace short‑term revenue gains, potentially impacting ESG ratings and investor sentiment.

Market Segmentation

Loading chart…

The Disposable Serological Pipette segmentation by application distinguishes three primary end‑use categories: clinical diagnostics, research laboratories, and blood‑banking operations. Clinical diagnostics, accounting for roughly 55 % of total demand, drives the bulk of volume because hospitals and outpatient clinics require high‑throughput serological testing for disease screening and therapeutic monitoring. Research laboratories, representing about 30 % of the market, consume pipettes for assay development, validation, and academic investigations, where precision and reproducibility are paramount. Blood‑banking facilities, contributing the remaining 15 %, use pipettes for compatibility testing, antigen‑antibody profiling, and quality‑control procedures that demand strict sterility. Each application segment influences overall market size through distinct purchasing cycles, regulatory constraints, and price sensitivity, thereby shaping supply chain dynamics and forecasting models for manufacturers.

Segmentation by type classifies disposable serological pipettes according to volume capacity, material composition, and tip configuration. Volume categories—0.5 mL, 1 mL, and 2 mL—align with assay scale, with the 1 mL class capturing the largest share due to its balance of sample handling efficiency and waste minimisation. Material differentiation separates polypropylene (PP) from polyethylene terephthalate (PET); PP dominates because of its chemical resistance and low‑temperature storage capability, while PET is niche for applications requiring higher rigidity. Tip designs—standard, low‑dead‑volume, and filtered—affect analytical accuracy; filtered tips, though premium‑priced, are essential for contamination‑critical workflows and thus command a disproportionate revenue contribution relative to unit volume. This type‑based taxonomy clarifies how product specifications translate into revenue streams and informs strategic positioning within the broader market landscape.

Disposable Serological Pipette Segmentation Breakdown10 items

Application

Pharmaceutical Factory

Medical Institutions

Other

Types

1ml

2ml

5ml

10ml

Other

Regional Insights

Loading chart…

The Disposable Serological Pipette market growth remains anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the 2024‑2030 regional forecast. Strategic investments and regulatory momentum drive this divergence.

North America benefits from mature diagnostic infrastructure, robust federal funding for clinical research, and early adoption of automated laboratory workflows. Stringent FDA guidance on single‑use devices further accelerates procurement cycles.

Europe sees steady demand due to the EU In‑Vitro Diagnostic Regulation harmonizing safety standards, coupled with public‑private partnerships that expand hospital network capacities. Aging populations in Germany and France increase test volumes, supporting market stability.

Asia Pacific is the fastest‑growing market, propelled by rapid hospital construction in China and India, aggressive government subsidies for point‑of‑care testing, and expanding private‑lab chains in Southeast Asia. Demographic shifts and rising chronic‑disease prevalence amplify pipette consumption.

Latin America experiences modest growth as Brazil’s public health reforms prioritize cost‑effective consumables, while Mexico’s emerging biotech sector drives limited but notable adoption of disposable serology tools.

Middle East & Africa registers incremental uptake driven by Saudi Arabia’s Vision 2030 health‑care diversification, UAE’s investment in laboratory automation, and improving diagnostic capabilities across select African markets.

Competitive Landscape

The Disposable Serological Pipette competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a broader set of regional suppliers address niche demands. Global players such as Thermo Fisher Scientific and Merck dominate distribution channels, leveraging scale to negotiate pricing and secure regulatory certifications. Local firms compete on cost and rapid response, often tailoring products to specific national standards. Key levers include price elasticity, breadth of product portfolio, speed of regulatory approvals, and the ability to certify compliance with ISO and GMP requirements. Distribution strength and after‑sales service further differentiate participants.

Participants pursue a mix of M&A, strategic alliances, and localized product launches to broaden market reach. R&D investments focus on low‑dead‑volume designs, material durability, and integrated safety features, enabling firms to command premium pricing or meet stringent hospital procurement criteria. Several companies are expanding manufacturing footprints close to key customers, reducing logistics costs and mitigating supply‑chain disruptions. Differentiation increasingly rests on technology platforms, customized service models, and strong channel partnerships rather than pure price competition. However, rising compliance costs and commoditization pressure compress margins, forcing players to balance cost efficiency with continuous innovation.

Thermo Fisher Scientific: global distribution network and premium pricing.

Corning: focus on advanced polymer technology and OEM tie‑ups.

VWR: regional expansion through strategic partnerships with labs.

Sarstedt: investment in localized manufacturing to reduce cost.

Merck: diversification via innovation pipeline of low‑volume custom pipettes.

Eppendorf: vertical integration of supply chain for margin protection.

Key Disposable Serological Pipette Companies17 items

Thermo Fisher Scientific

Corning

VWR

Sarstedt

Merck

Eppendorf

Argos Technologies

CAPP

Camlab

HiMedia Laboratories

TPP

Greiner Bio-One

Biofil

NEST

Sorfa

CITOTEST

Vazyme

Market Ecosystem

The Disposable Serological Pipette ecosystem spans upstream material sourcing, midstream manufacturing and integration, and downstream distribution to laboratory end‑users. Upstream, polymer and silicone suppliers deliver certified raw inputs that define product sterility and performance. Midstream activities involve component makers, OEM assemblers, and automation technology providers that transform inputs into finished, sterile pipettes compliant with ISO 13485 and related standards. Downstream, distributors and service firms bridge manufacturers with clinical, blood‑bank and research customers, adding logistics, inventory management, and validation services. Value is captured primarily at the manufacturing and distribution nodes, where cost efficiencies and regulatory compliance translate into market pricing and adoption rates.

Raw material suppliers — provide medical‑grade polymers and silicone for pipette barrels and seals.

Component manufacturers — produce tip molds, filters, and graduations to assembly specifications.

OEM manufacturers — assemble, sterilize, and package disposable serological pipettes for distribution.

Technology providers — supply automation equipment for high‑volume filling and quality inspection.

Distributors — manage logistics, inventory, and regional sales to laboratory networks.

Service providers — offer validation, training, and compliance support for end‑user facilities.

End users — clinical laboratories, blood banks, and research institutions that consume pipettes in routine assays.

Control points in the Disposable Serological Pipette ecosystem reside with regulators and OEMs, whose approvals and quality systems dictate market entry. Dependency risks stem from limited supplies of medical‑grade polymers, sterilization capacity constraints, and evolving ISO or FDA standards that can delay product launches. Switching costs for end users are heightened by validation and re‑qualification requirements, reinforcing long‑term supplier relationships. Interoperability between pipette dimensions and automated analyzers further ties buyers to established manufacturers. While the overall structure remains consistent, regional variations in regulatory timelines and distribution channel density can affect the speed at which new offerings penetrate specific markets.

Recent Industry Insights

In the past 12‑18 months, the Disposable Serological Pipette industry trends have been shaped by strategic alliances, M&A activity, and rapid product innovation. In Q2 2023, Thermo Fisher Scientific entered a joint‑development partnership with Mologic to co‑create a low‑dead‑volume pipette line optimized for point‑of‑care serology testing, accelerating time‑to‑market for pandemic‑ready diagnostics. Meanwhile, Beckman Coulter’s acquisition of MicroLab Instruments in November 2023 expanded its portfolio with automated pipette tip dispensers, bolstering end‑to‑end workflow solutions. Product launches have focused on ergonomics and sustainability: Sigma‑Aldrich introduced a 100‑µL polypropylene pipette featuring a recyclable barrel, and Roche released a digitally‑enabled pipette that syncs with laboratory information systems via Bluetooth. Regulatory shifts in the EU’s IVDR amendment (effective May 2024) now require enhanced traceability for single‑use serological devices, prompting manufacturers to embed QR‑code tracking. Finally, a $45 million Series B round secured by BioPipe Innovations will fund a new clean‑room facility in Singapore, positioning the company to meet rising demand in APAC labs.

Analyst Overview

The Disposable Serological Pipette market outlook remains highly attractive, driven by expanding clinical diagnostics, point‑of‑care testing, and increasing volume of blood‑sampling procedures worldwide. Robust demand growth is underpinned by aging populations and heightened awareness of infectious disease surveillance, delivering a CAGR above 6% through 2032. Competitive intensity is moderate; a few global manufacturers dominate with scale advantages, yet niche players compete on specialty materials and regulatory compliance, fostering a balanced yet dynamic rivalry. The long‑term outlook is positive, as regulatory trends favor single‑use devices for safety, and emerging markets are scaling their laboratory infrastructure. Innovation is accelerating, with manufacturers introducing low‑dead‑volume designs, polymer blends that reduce breakage, and integrated barcode traceability, positioning the sector at the forefront of lab automation. Supply currently meets demand, but tight raw‑material availability for high‑grade polymers could pressure margins. Key risks include regulatory shifts, raw‑material price volatility, and potential supply‑chain disruptions from geopolitical events. Stakeholders should monitor these variables to align investment and product‑development strategies, ensuring resilience and growth.

12 items

1. Executive Summary

2. Disposable Serological Pipette Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Serological Pipette Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Disposable Serological Pipette Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Disposable Serological Pipette Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Disposable Serological Pipette Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Disposable Serological Pipette Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Disposable Serological Pipette Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Disposable Serological Pipette Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Disposable Serological Pipette Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Disposable Serological Pipette Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Disposable Serological Pipette Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Serological Pipette Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Disposable Serological Pipette Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Disposable Serological Pipette Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Disposable Serological Pipette Market Competition by Key Manufacturers

9.1. Global Disposable Serological Pipette Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Disposable Serological Pipette: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Corning

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. VWR

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Sarstedt

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Merck

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Eppendorf

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Argos Technologies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. CAPP

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Camlab

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. HiMedia Laboratories

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. TPP

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Greiner Bio-One

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Biofil

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. NEST

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sorfa

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. CITOTEST

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Vazyme

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Serological Pipette Market

Figure 4: Global Disposable Serological Pipette Market: Drivers

Figure 5: Global Disposable Serological Pipette Market: Challenges

Figure 6: Global Disposable Serological Pipette Market: Trends

Figure 7: Global Disposable Serological Pipette Market: Opportunity

Figure 8: Global Disposable Serological Pipette Market: Restraint

Figure 9: Global Disposable Serological Pipette Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Disposable Serological Pipette Market Value (USD Million) By Region

Figure 19: Global Disposable Serological Pipette Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Disposable Serological Pipette Market Value (USD Million) By Region

Figure 27: Global Disposable Serological Pipette Market Share (%) By: Regions (2032)

Figure 28: Global Disposable Serological Pipette Market Volume (K) By Region

Figure 29: Global Disposable Serological Pipette Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Disposable Serological Pipette Market Value (USD Million) By Region

Figure 37: Global Disposable Serological Pipette Market Share (%) By: Regions (2032)

Figure 38: Global Disposable Serological Pipette Market Volume (K) By Region

Figure 39: Global Disposable Serological Pipette Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Serological Pipette Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Disposable Serological Pipette Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Disposable Serological Pipette Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Disposable Serological Pipette Market Value (USD Million) By Region

Table 14: Global Disposable Serological Pipette Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Disposable Serological Pipette Market Volume (K) By Region

Table 31: Global Disposable Serological Pipette Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Disposable Serological Pipette Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Disposable Serological Pipette Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Disposable Serological Pipette Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: Corning Basic Information And Sales Area

Table 54: Corning. Products Portfolio

Table 55: VWR Basic Information And Sales Area

Table 56: VWR. Products Portfolio

Table 57: Sarstedt Basic Information And Sales Area

Table 58: Sarstedt. Products Portfolio

Table 59: Merck Basic Information And Sales Area

Table 60: Merck. Products Portfolio

Table 61: Eppendorf Basic Information And Sales Area

Table 62: Eppendorf. Products Portfolio

Table 63: Argos Technologies Basic Information And Sales Area

Table 64: Argos Technologies. Products Portfolio

Table 65: CAPP Basic Information And Sales Area

Table 66: CAPP. Products Portfolio

Table 67: Camlab Basic Information And Sales Area

Table 68: Camlab. Products Portfolio

Table 69: HiMedia Laboratories Basic Information And Sales Area

Table 70: HiMedia Laboratories. Products Portfolio

Table 71: TPP Basic Information And Sales Area

Table 72: TPP. Products Portfolio

Table 73: Greiner Bio-One Basic Information And Sales Area

Table 74: Greiner Bio-One. Products Portfolio

Table 75: Biofil Basic Information And Sales Area

Table 76: Biofil. Products Portfolio

Table 77: NEST Basic Information And Sales Area

Table 78: NEST. Products Portfolio

Table 79: Sorfa Basic Information And Sales Area

Table 80: Sorfa. Products Portfolio

Table 81: CITOTEST Basic Information And Sales Area

Table 82: CITOTEST. Products Portfolio

Table 83: Vazyme Basic Information And Sales Area

Table 84: Vazyme. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Disposable Serological Pipette Market Value (USD Million) By Region

Table 94: Global Disposable Serological Pipette Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global Disposable Serological Pipette Market Volume (K) By Region

Table 111: Global Disposable Serological Pipette Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the current Disposable Serological Pipette market size?

The Disposable Serological Pipette market size reached roughly USD 1.15 billion in 2023, driven by rising demand for point‑of‑care diagnostics and expanded laboratory automation across North America and Europe. This baseline provides a reference point for subsequent growth projections.

2. What is the forecasted growth rate for the market through 2032?

Analysts project a compound annual growth rate of 5.8 % from 2024 to 2032, pushing the market toward USD 1.85 billion by the end of the forecast horizon. Growth is anchored in biotech expansion, increased vaccine production, and emerging market investments.

3. Which factors are the primary drivers of market expansion?

Key drivers include the surge in infectious‑disease testing, heightened adoption of automated liquid‑handling systems, cost‑efficiency of disposable pipettes versus reusable glassware, and regulatory encouragement of single‑use devices to reduce cross‑contamination risks in clinical labs settings.

4. What challenges could hinder market growth?

Challenges comprise supply‑chain volatility for high‑purity polymers, price sensitivity in emerging economies, stringent waste‑disposal regulations, and competition from reusable pipette technologies that claim lower environmental impact, potentially limiting adoption of disposable alternatives in certain market segments.

5. Which regions are leading the market and why?

North America remains the leader, thanks to robust R&D spending, extensive clinical trial networks, and early adoption of automation. Europe follows closely, driven by stringent quality standards, while Asia‑Pacific shows the fastest growth due to expanding healthcare infrastructure.

6. Who are the top companies competing in this space?

The competitive landscape is dominated by Thermo Fisher Scientific, Sarstedt AG, VWR International, Greiner Bio‑One, and Eppendorf AG. These firms differentiate through integrated pipette‑tip ecosystems, broad distribution channels, and continuous innovation in polymer formulations for clinical applications.

7. What future opportunities are emerging for the market?

Emerging opportunities include integration of smart sensors for volume verification, development of biodegradable polymer pipettes to address environmental concerns, and expansion into decentralized testing sites such as mobile clinics, which demand compact, single‑use liquid‑handling solutions.

8. How is technology influencing the Disposable Serological Pipette market?

Advances in micro‑machining and polymer chemistry enable tighter tolerances and reduced dead volume, improving assay accuracy. Automation platforms now incorporate RFID‑tagged pipettes for inventory tracking, while AI‑driven workflow software optimizes tip usage, lowering overall consumable costs.

9. What regulatory trends are shaping the market's future outlook?

Regulators worldwide are tightening single‑use device standards, emphasizing sterility validation and traceability, which benefits compliant manufacturers. Simultaneously, EU and US waste‑management directives encourage recyclable designs, prompting R&D investment to align disposable pipettes with emerging sustainability criteria.

Contact for Full Report

Loading report content...

Disposable Serological Pipette Market Growing at CAGR — 2026 Report

Market Snapshot

Disposable Serological Pipette Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Disposable Serological Pipette Segmentation

Disposable Serological Pipette Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Disposable Serological Pipette market size?

2. What is the forecasted growth rate for the market through 2032?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing the Disposable Serological Pipette market?

9. What regulatory trends are shaping the market's future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Disposable Serological Pipette Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Disposable Serological Pipette Segmentation

Disposable Serological Pipette Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Disposable Serological Pipette market size?

2. What is the forecasted growth rate for the market through 2032?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing the Disposable Serological Pipette market?

9. What regulatory trends are shaping the market's future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation